QT
APGE

Quantbot Technologies’s Apogee Therapeutics APGE Stock Holding History

Quantbot Technologies’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$836K Buy
+6,302
New +$568K 0.03% 709
2026
Q1 		– Sell
-3,340
Closed -$252K – 1690
2025
Q4 		$252K Buy
3,340
+933
+39% +$58.8K 0.01% 1170
2025
Q3 		$95.6K Buy
+2,407
New +$91.9K ﹤0.01% 1436
2025
Q2 		– Sell
-5
Closed -$187 – 1613
2025
Q1 		$187 Buy
+5
New +$193 ﹤0.01% 1411

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Quantbot Technologies's APGE Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 6,302 shares worth $836K. The stake represents 0.03% of the portfolio and ranks #709 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in APGE as recently as Q4 2025.

Quantbot Technologies first reported a position in APGE in Q1 2025 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Quantbot Technologies held 6,302 shares of Apogee Therapeutics worth $836K as of Q2 2026.
  • Apogee Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Apogee Therapeutics made up 0.03% of Quantbot Technologies's portfolio in Q2 2026, its #709 holding.
  • Quantbot Technologies first reported a position in Apogee Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.